Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Evaluating the utility of personal genomic information.

Foster MW, Mulvihill JJ, Sharp RR.

Genet Med. 2009 Aug;11(8):570-4. doi: 10.1097/GIM.0b013e3181a2743e.

PMID:
19478683
2.

Personal utility and genomic information: look before you leap.

Grosse SD, McBride CM, Evans JP, Khoury MJ.

Genet Med. 2009 Aug;11(8):575-6. doi: 10.1097/GIM.0b013e3181af0a80. No abstract available.

3.

The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop.

Khoury MJ, McBride CM, Schully SD, Ioannidis JP, Feero WG, Janssens AC, Gwinn M, Simons-Morton DG, Bernhardt JM, Cargill M, Chanock SJ, Church GM, Coates RJ, Collins FS, Croyle RT, Davis BR, Downing GJ, Duross A, Friedman S, Gail MH, Ginsburg GS, Green RC, Greene MH, Greenland P, Gulcher JR, Hsu A, Hudson KL, Kardia SL, Kimmel PL, Lauer MS, Miller AM, Offit K, Ransohoff DF, Roberts JS, Rasooly RS, Stefansson K, Terry SF, Teutsch SM, Trepanier A, Wanke KL, Witte JS, Xu J; Centers for Disease Control and Prevention.

Genet Med. 2009 Aug;11(8):559-67. doi: 10.1097/GIM.0b013e3181b13a6c.

4.

American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

American Society of Clinical Oncology.

J Clin Oncol. 2003 Jun 15;21(12):2397-406. Epub 2003 Apr 11.

PMID:
12692171
5.

Health care provider and consumer awareness, perceptions, and use of direct-to-consumer personal genomic tests, United States, 2008.

Kolor K, Liu T, St Pierre J, Khoury MJ.

Genet Med. 2009 Aug;11(8):595. doi: 10.1097/GIM.0b013e3181b1cc2c. No abstract available.

PMID:
19680046
6.

Recommendations from the EGAPP Working Group: does genomic profiling to assess type 2 diabetes risk improve health outcomes?

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group; Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.

Genet Med. 2013 Aug;15(8):612-7. doi: 10.1038/gim.2013.9. Epub 2013 Mar 14.

PMID:
23492873
7.

Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants.

Gollust SE, Gordon ES, Zayac C, Griffin G, Christman MF, Pyeritz RE, Wawak L, Bernhardt BA.

Public Health Genomics. 2012;15(1):22-30. doi: 10.1159/000327296. Epub 2011 Jun 3.

8.

Genomic and personalized medicine: foundations and applications.

Ginsburg GS, Willard HF.

Transl Res. 2009 Dec;154(6):277-87. doi: 10.1016/j.trsl.2009.09.005. Epub 2009 Oct 1. Review.

PMID:
19931193
9.

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].

Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly.

Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. French.

PMID:
19748369
10.

[The origin of informed consent].

Mallardi V.

Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27. Italian.

PMID:
16602332
11.

Closing the gap between knowledge and clinical application: challenges for genomic translation.

Burke W, Korngiebel DM.

PLoS Genet. 2015 Feb 26;11(2):e1004978. doi: 10.1371/journal.pgen.1004978. eCollection 2015. Review.

12.

Personalized medicine and disruptive innovation: implications for technology assessment.

Schulman KA, Vidal AV, Ackerly DC.

Genet Med. 2009 Aug;11(8):577-81. doi: 10.1097/GIM.0b013e3181ae0935. No abstract available.

PMID:
19606052
13.

Risk management frameworks for human health and environmental risks.

Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S.

J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. Review.

PMID:
14698953
14.

Impact of delivery models on understanding genomic risk for type 2 diabetes.

Haga SB, Barry WT, Mills R, Svetkey L, Suchindran S, Willard HF, Ginsburg GS.

Public Health Genomics. 2014;17(2):95-104. doi: 10.1159/000358413. Epub 2014 Feb 27.

15.

Costs and benefits of diagnosing familial breast cancer.

Heimdal K, Maehle L, Møller P.

Dis Markers. 1999 Oct;15(1-3):167-73.

16.

Personal genomics services: whose genomes?

Gurwitz D, Bregman-Eschet Y.

Eur J Hum Genet. 2009 Jul;17(7):883-9. doi: 10.1038/ejhg.2008.254. Epub 2009 Mar 4.

17.

Benefit adequacy among elderly Social Security retired-worker beneficiaries and the SSI federal benefit rate.

Rupp K, Strand A, Davies P, Sears J.

Soc Secur Bull. 2007;67(3):29-51.

PMID:
18605217
18.
19.

Consent for use of personal information for health research: do people with potentially stigmatizing health conditions and the general public differ in their opinions?

Willison DJ, Steeves V, Charles C, Schwartz L, Ranford J, Agarwal G, Cheng J, Thabane L.

BMC Med Ethics. 2009 Jul 24;10:10. doi: 10.1186/1472-6939-10-10.

20.

Cost-effectiveness of hospice care.

Robinson BE, Pham H.

Clin Geriatr Med. 1996 May;12(2):417-28.

PMID:
8799358

Supplemental Content

Support Center